Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward

Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward

Guardado en:
Detalles Bibliográficos
Autores principales: David Munn, Maria Rain Jennings, John Blazeck
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/26073dd770a9408198fc42444cc07e87
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:26073dd770a9408198fc42444cc07e87
record_format dspace
spelling oai:doaj.org-article:26073dd770a9408198fc42444cc07e872021-11-29T19:30:06ZImmunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward10.1136/jitc-2021-0030132051-1426https://doaj.org/article/26073dd770a9408198fc42444cc07e872021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e003013.fullhttps://doaj.org/toc/2051-1426David MunnMaria Rain JenningsJohn BlazeckBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
David Munn
Maria Rain Jennings
John Blazeck
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
format article
author David Munn
Maria Rain Jennings
John Blazeck
author_facet David Munn
Maria Rain Jennings
John Blazeck
author_sort David Munn
title Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
title_short Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
title_full Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
title_fullStr Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
title_full_unstemmed Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
title_sort immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/26073dd770a9408198fc42444cc07e87
work_keys_str_mv AT davidmunn immunosuppressivemetabolitesintumoralimmuneevasionredundanciesclinicaleffortsandpathwaysforward
AT mariarainjennings immunosuppressivemetabolitesintumoralimmuneevasionredundanciesclinicaleffortsandpathwaysforward
AT johnblazeck immunosuppressivemetabolitesintumoralimmuneevasionredundanciesclinicaleffortsandpathwaysforward
_version_ 1718407092375650304

Ejemplares similares